ASB2 and acute myeloid leukemia: The study then showed that FTO decreases m6A levels on the UTRs of ASB2 and RARA through its eraser activity, thereby contributing to the response of AML cells to all-trans-retinoic acid treatment and leukemogenesis (Li et al., 2017).